Eyepoint Pharmaceuticals shares owned by Cormorant Asset Management
Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Cormorant Asset Management
from 13F filings
Historical chart of Cormorant Asset Management investment in Eyepoint Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eyepoint Pharmaceuticals held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eyepoint Pharmaceuticals by Cormorant Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $119M | 8.3M | 14.24 |
| 2025-06-30 | $78M | 8.3M | 9.41 |
| 2025-03-31 | $45M | 8.3M | 5.42 |
| 2024-12-31 | $62M | 8.3M | 7.45 |
| 2024-09-30 | $67M | 8.3M | 7.99 |
| 2024-06-30 | $72M | 8.3M | 8.70 |
| 2024-03-31 | $143M | 6.9M | 20.67 |
| 2023-12-31 | $140M | 6.0M | 23.11 |
| 2023-09-30 | $26M | 3.2M | 7.99 |
| 2023-06-30 | $28M | 3.2M | 8.70 |
| 2023-03-31 | $662k | 225k | 2.94 |
More positions owned by Cormorant Asset Management
View all positions for Cormorant Asset Management